Citation Impact
Citing Papers
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
2012 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
2001 Standout
Transplant Accommodation in Highly Sensitized Patients: A Potential Role for Bcl-xL and Alloantibody
2001
Modifying the sugar icing on the transplantation cake
2016
Treatment of osteopenia and osteoporosis in renal transplant children and adolescents
2004
Synthetic glycobiology: exploits in the Golgi compartment
2006 StandoutNobel
Impact of donor infections on outcome of orthotopic liver transplantation
2003
PREVENTION OF BONE LOSS IN CARDIAC TRANSPLANT RECIPIENTS
1996
Reducing Gal expression on the pig organ – a retrospective review
2005
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Tolerance, Danger, and the Extended Family
1994 Standout
Biological roles of glycans
2016 Standout
Nocardiosis at the Turn of the Century
2009 Standout
Euthyroid Sick Syndrome: Is It a Misnomer?
1997
Transmission of Toxoplasma gondii Infection by Liver Transplantation
1995
Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
2007 Standout
Effect of Ibandronate on Bone Loss and Renal Function after Kidney Transplantation
2001
Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis
1995
Directing Flux in Glycan Biosynthetic Pathways with a Small Molecule Switch
2004 StandoutNobel
Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria
2002 Standout
Chemical approaches to glycobiology and emerging carbohydrate-based therapeutic agents
1998 StandoutNobel
Successful toxoplasmosis prophylaxis after orthotopic cardiac transplantation with trimethoprim-sulfamethoxazole1
2003
Infection of human cells by an endogenous retrovirus of pigs
1997 Standout
Xenotransplantation and other means of organ replacement
2001
Infection in Solid-Organ Transplant Recipients
2007 Standout
Infection in Organ-Transplant Recipients
1998 Standout
High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry
1999
The Use of Donor and Recipient Screening for Toxoplasma in the Era of Universal Trimethoprim Sulfamethoxazole Prophylaxis
2008
Adenovirus-mediated gene transfer of the β2-adrenergic receptor to donor hearts enhances cardiac function
1999 StandoutNobel
Desensitization of myocardial β-adrenergic receptors and deterioration of left ventricular function after brain death
1995
Use of potentially infected donor hearts for cardiac transplantation
1990
Toxoplasmosis in Pediatric Recipients of Heart Transplants
1992
Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
2014 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
ABO-incompatible organ and bone marrow transplantation: current status.
2003
The challenges of infection in transplantation: donor-derived infections
2005
Infections in solid-organ transplant recipients
1997
Loss of endothelium-dependent vasodilatation and nitric oxide release after myocardial protection with University of Wisconsin solution
1994 StandoutNobel
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
PNEUMOCYSTIS CARINII AND PARASITIC INFECTIONS IN TRANSPLANTATION
1995
Immunological monitoring of lung transplant patients by bronchoalveolar lavage analysis
1992
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
Superior qualities of University of Wisconsin solution for ex vivo preservation of the pig heart
1992
Timing and quantification of bone loss in cardiac transplant recipients
1995
Aspergillus fumigatusand Aspergillosis
1999 Standout
Euthyroid Sick Syndrome: Is It a Misnomer?
1997
Antimicrobial strategies in the care of organ transplant recipients
1993
Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes.
1993
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
The Influence of Allogeneic Cells on the Human T and B Cell Repertoire
1990 Science
Works of Cooper Dk being referenced
Screening of baboons as potential liver donors for humans.
1996
Successful management of symptomatic cytomegalovirus disease with ganciclovir after heart transplantation.
1992
Histocompatibility matching between humans and baboons.
1990
Hemodynamic and myocardial histologic and ultrastructural studies on baboons from 3 to 27 months following autotransplantation of hearts stored by hypothermic perfusion for 24 or 48 hours.
1987
A novel approach to "neutralization" of preformed antibodies: cardiac allotransplantation across the ABO blood group barrier as a paradigm of discordant transplantation.
1992
Triiodothyronine therapy in the cardiac transplant recipient.
1988
Specific intravenous carbohydrate therapy: a new approach to the inhibition of antibody-mediated rejection following ABO-incompatible allografting and discordant xenografting.
1993
Prevention of loss of vertebral bone density in heart transplant patients.
1992
Ratites (ostrich, emu) as potential heart donors for humans: immunologic considerations.
1996
Myocardial and pulmonary histopathologic changes.
1988
Prolongation of cardiac xenograft (vervet monkey to baboon) function by a combination of total lymphoid irradiation and immunosuppressive drug therapy.
1987
Hyperacute rejection in a discordant (pig to baboon) cardiac xenograft model.
1987
Toxoplasmosis of donor and recipient hearts after heterotopic cardiac transplantation.
1983
Effect of pharmacologic immunosuppression on donor heart survival in a closely related nonhuman primate xenograft model.
1990
Added effects of organ (heart) storage after brain death in the experimental animal.
1988
Acute pulmonary rejection precedes cardiac rejection following heart-lung transplantation in a primate model.
1987
Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon.
1988